Free Trial
→ Your chance to get on the next “60-Second Trade” (From WealthPress) (Ad) Free LXRX Stock Alerts

Lexicon Pharmaceuticals (LXRX) Insider Trading & Ownership

Lexicon Pharmaceuticals logo
$0.71 -0.01 (-1.23%)
(As of 12/20/2024 05:45 PM ET)
Compare

Lexicon Pharmaceuticals (NASDAQ:LXRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.80%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$113.70 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get LXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LXRX Insider Buying and Selling by Quarter

Ad WealthPress
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
>> You can grab your FREE, laminated copies right here << 

Lexicon Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/16/2023Lonnel CoatsCEOBuy90,000$1.05$94,500.00  
11/10/2023Lonnel CoatsCEOBuy10,000$1.01$10,100.00  
10/12/2023Raymond DebbaneDirectorBuy148,820$1.03$153,284.60  
10/10/2023Raymond DebbaneDirectorBuy508,306$1.14$579,468.84  
9/14/2023Jeffrey L WadeCFOBuy10,000$1.38$13,800.00  
8/4/2023Wendy McdermottVPBuy6,000$1.84$11,040.00  
6/29/2023Lonnel CoatsCEOBuy10,000$2.16$21,600.00  
6/26/2023Lonnel CoatsCEOBuy10,000$2.18$21,800.00  
6/23/2023Wendy McdermottVPBuy10,000$2.43$24,300.00  
6/22/2023Lonnel CoatsCEOBuy40,000$2.31$92,400.00  
6/20/2023Jeffrey L WadeCFOBuy12,000$2.33$27,960.00  
6/5/2023International S.C.A. ArtalDirectorBuy27,775,050$2.60$72,215,130.00  
8/1/2022International S.C.A. ArtalDirectorBuy16,173,800$2.50$40,434,500.00  
(Data available from 1/1/2013 forward)

LXRX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lexicon Pharmaceuticals includes International S.C.A. Artal, Jeffrey L Wade, Lonnel Coats, Raymond Debbane, and Wendy Mcdermott. Learn more on insiders at LXRX.

6.80% of Lexicon Pharmaceuticals stock is owned by insiders. Learn more on LXRX's insider holdings.

The following insiders have purchased LXRX shares in the last 24 months: International S.C.A. Artal ($72,215,130.00), Jeffrey L Wade ($41,760.00), Lonnel Coats ($240,400.00), Raymond Debbane ($732,753.44), and Wendy Mcdermott ($35,340.00).

Insiders have purchased a total of 28,630,176 LXRX shares in the last 24 months for a total of $73,265,383.44 bought.

Lexicon Pharmaceuticals Key Executives

  • Mr. Jeffrey L. Wade J.D. (Age 59)
    President & COO
    Compensation: $752.05k
  • Mr. Brian T. Crum (Age 51)
    Senior VP, General Counsel & Secretary
    Compensation: $596.48k
  • Dr. Alan J. Main Ph.D. (Age 70)
    Executive Vice President of Innovation & Chemical Sciences
    Compensation: $576.96k
  • Dr. Craig B. Granowitz M.D. (Age 59)
    Ph.D., Senior VP & Chief Medical Officer
    Compensation: $652.48k
  • Dr. Michael Exton Ph.D. (Age 54)
    CEO & Director
  • Ms. Kristen L. Alexander (Age 56)
    Vice President of Finance & Accounting
  • Ms. Lisa M. DeFrancesco (Age 45)
    Vice President of Investor Relations, Corporate Strategy & Communications
  • Mr. Dixon Terry
    Vice President of Compliance
  • Ms. Carrie Siragusa
    Vice President of Marketing
  • Ms. Desiree Gendron
    Vice President of Sales & Training

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:LXRX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...
Crypto 101 Media | Sponsored
AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...
Porter & Company | Sponsored
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...
Weiss Ratings | Sponsored
Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average A...
MyBankTracker | Sponsored
MUST SEE: The most important video in the world right now?
If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...
InvestorPlace | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...
Banyan Hill Publishing | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Altcoin season moves fast, and those who hesitate are left behind. The window is closing.
Crypto Swap Profits | Sponsored
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...
Brownstone Research | Sponsored